Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Brian Freed to Kidney Transplantation

This is a "connection" page, showing publications Brian Freed has written about Kidney Transplantation.

 
Connection Strength
 
 
 
0.776
 
  1. Supon P, Constantino D, Hao P, Cagle L, Hahn A, Conti DJ, Freed BM. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection. Transplantation. 2001 Feb 27; 71(4):577-80.
    View in: PubMed
    Score: 0.125
  2. Davis S, Gralla J, Klem P, Tong S, Wedermyer G, Freed B, Wiseman A, Cooper JE. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation. Am J Transplant. 2018 04; 18(4):907-915.
    View in: PubMed
    Score: 0.099
  3. Conti DJ, Shen G, Singh T, Isenberg A, Freed BM. Ganciclovir prophylaxis of cytomegalovirus disease. Transplant Proc. 1997 Feb-Mar; 29(1-2):804-6.
    View in: PubMed
    Score: 0.094
  4. Adebiyi OO, Gralla J, Klem P, Freed B, Davis S, Wiseman AC, Cooper JE. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients. Am J Transplant. 2016 12; 16(12):3458-3467.
    View in: PubMed
    Score: 0.090
  5. Lempert N, Laffin RJ, Fitzgerald K, Freed BM. Elevation of serum C-reactive protein levels during graft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 2):1683-5.
    View in: PubMed
    Score: 0.047
  6. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant. 2006 Sep; 21(9):2625-9.
    View in: PubMed
    Score: 0.045
  7. Freed B, Walsh A, Pietrocola D, MacDowell R, Laffin R, Lempert N. Early detection of renal allograft rejection by serial monitoring of serum C-reactive protein. Transplantation. 1984 Feb; 37(2):215-18.
    View in: PubMed
    Score: 0.038
  8. Stites E, Renner B, Laskowski J, Le Quintrec M, You Z, Freed B, Cooper J, Jalal D, Thurman JM. Complement fragments are biomarkers of antibody-mediated endothelial injury. Mol Immunol. 2020 02; 118:142-152.
    View in: PubMed
    Score: 0.029
  9. Isenberg A, Singh TP, Shen GK, Freed BM, Conti DJ. Selective CellCept therapy in high-risk renal transplant recipients. Transplant Proc. 1998 Jun; 30(4):1188-9.
    View in: PubMed
    Score: 0.026
  10. Hughes SE, Xiao S, Perera S, Fluno C, Hasselbarth J, Jayasankar V, Singh J, Del Rosario A, Freed BM, Singh TP, Lempert N, Conti DJ, Gruber SA. Local immunosuppression of canine renal allografts with 15-deoxyspergualin. Transplant Proc. 1996 Aug; 28(4):2054-5.
    View in: PubMed
    Score: 0.023
  11. Gruber SA, Gallichio M, Rosano TG, Hughes SE, Singh TP, Lempert N, Conti DJ, Hasselbarth J, Freed BM, Stein D, Drusano G. Comparative pharmacokinetics of cyclosporine A and cyclosporine G in renal allograft recipients. Transplant Proc. 1996 Apr; 28(2):892.
    View in: PubMed
    Score: 0.022
  12. Conti DJ, Freed BM, Singh TP, Gallichio M, Gruber SA, Lempert N. Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients. Arch Surg. 1995 Nov; 130(11):1217-21; discussion 1221-2.
    View in: PubMed
    Score: 0.022
  13. Conti DJ, Freed BM, Gruber SA, Singh TP, Gallichio M, Lempert N. Impact of retransplant status on delayed graft function: an analysis of paired cadaver kidneys. Transplant Proc. 1995 Feb; 27(1):1070-1.
    View in: PubMed
    Score: 0.020
  14. Singh TP, Gruber SA, Lempert N, Freed B, Conti DJ. Efficacy of cytomegalovirus prophylaxis in renal retransplantation. Transplant Proc. 1995 Feb; 27(1):964-5.
    View in: PubMed
    Score: 0.020
  15. Conti DJ, Freed BM, Gruber SA, Lempert N. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg. 1994 Apr; 129(4):443-7.
    View in: PubMed
    Score: 0.019
  16. Conti DJ, Freed BM, Lempert N. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease. Transplant Proc. 1993 Feb; 25(1 Pt 2):1421-2.
    View in: PubMed
    Score: 0.018
  17. Freed BM, Stevens C, Zhang G, Rosano TG, Lempert N. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses. Transplant Proc. 1988 Apr; 20(2 Suppl 2):233-9.
    View in: PubMed
    Score: 0.013
  18. Rosano TG, Pell MA, Freed BM, Dybas MT, Lempert N. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Transplant Proc. 1988 Apr; 20(2 Suppl 2):330-8.
    View in: PubMed
    Score: 0.013
  19. Rosano TG, Freed BM, Cerilli J, Lempert N. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation. 1986 Sep; 42(3):262-7.
    View in: PubMed
    Score: 0.011
  20. Rosano TG, Freed BM, Pell MA, Lempert N. Cyclosporine metabolites in human blood and renal tissue. Transplant Proc. 1986 Dec; 18(6 Suppl 5):35-40.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)